GPC3 and hepatocellular carcinoma: Nevertheless, due to the complexity of the process, its poor generalization, and interpretability of the model, its application still faces multiple challenges (19, 20) in clinical practice, which necessitates the urgent development of a feasible and quantitative method capable of predicting the GPC3 status in HCC.